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Arf and Rab proteins, members of small GTPases superfamily, localize to specific subcellular compartments
and regulate intracellular trafficking. To carry out their cellular functions, Arfs/Rabs interact with numerous
and structurally diverse effector proteins. Over the years, a number of Arf/Rab:effector complexes have
been crystallized and their structures reveal shared binding modes including a-helical packing, b-b comple-
mentation, and heterotetrameric assemblies. We review available structural information and provide a
framework for in-depth analysis of complexes. The unifying features that we identify are organized into a
classification scheme for different modes of Arf/Rab:effector interactions, which includes ‘‘all-a-helical,’’
‘‘mixed a-helical,’’ ‘‘b-b zipping,’’ and ‘‘bivalent’’ modes of binding. Additionally, we highlight structural
determinants that are the basis of effector specificity. We conclude by expanding on functional implications
that are emerging from available structural information under our proposed classification scheme.ADP-ribosylation factor (Arf) and Rab proteins constitute two
distinct families within the superfamily of small GTPases (Takai
et al., 2001). These two families regulate various aspects of mem-
brane trafficking ineukaryotic organisms.Arf proteinsare required
for vesicle budding via recruitment of cargo-sorting coat proteins
(D’Souza-Schorey and Chavrier, 2006; Donaldson and Jackson,
2011). Rab proteins participate in various aspects of vesicle for-
mation, transport, docking, and fusion (Zerial and McBride,
2001). To perform their biological functions, Arf/Rab proteins
cycle between inactive (GDP-bound) and active (GTP-bound)
states, and in this latter state, they localize to a specificmembrane
and recruit numerous and structurally diverse effectors.
The molecular basis for the biological activity of Arf/Rab pro-
teins is a function of the conformational switch between the
GDP-bound and GTP-bound states. Segments of polypeptide
that are sensitive to theGDP/GTP cycle are called switch regions
and are mainly localized to the so-called switch 1 and switch
2 (Figure 1; Stroupe and Brunger, 2000). The g-phosphate of
GTP interacts with elements of switch 1, a loop, and switch 2,
a helix, and stabilizes their conformation. Thus, the switch
regions are the main binding sites for effectors, as well as for
guanine exchange factors (GEFs) and GTP-activating proteins
(GAPs), which can discriminate between the GDP- and the
GTP-bound conformations. Relative to other small GTPases,
Arf proteins contain two additional regions that are structurally
sensitive to the GDP/GTP cycle (Pasqualato et al., 2002): the
intervening region between switch 1 and 2 (a b hairpin termed
the interswitch; Figure 1); and an N-terminal a helix, unique to
Arfs. Upon GTP binding, both the interswitch and the N-terminal
a helix alsomove dramatically (Pasqualato et al., 2002). Thus, the
effective switch region, broadly defined as the segments that are
sensitive to the GDP versus GTP state, is larger in Arfs than in
other small GTPases.
The mode of membrane attachment differs between Arf and
Rab proteins, thus imposing distinct topological constraints in
effector recruitment. Most of the Arf proteins are myristoylated1284 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserat a glycine residue in position 2 of their N termini (Figure 1).
This site of lipid modification belongs to a region that differs
slightly in size among Arfs and folds generally as an amphipathic
a helix. Coupled to the myristate group, this a helix mediates
direct membrane association (Franco et al., 1993). In contrast,
Rab proteins aremodified at one or two cysteine residues at their
C termini by geranlygeranyl transferase (Leung et al., 2006). The
prenylation sites are typically a CXC sequence with the second
cysteine being the terminal residue. This conserved Rab motif
is preceded by approximately 30 residues that are not conserved
among the Rab family and are widely considered to be flexible.
Given the close proximity of the N and C termini of the G protein
fold, the identical faces of Arfs and Rabs are pointed toward the
bilayer. However, Arfs reside proximal to the lipid membrane via
theirN-terminal amphipathicahelices,whileRabspresumably lie
farther away and may have considerable mobility as a result of
their flexible tails that precede the prenylation site. For example,
Rab6 contains a 34-residue tail and has been modeled up to
105 A˚ away from the membrane surface (Burguete et al., 2008).
Altogether, these structural characteristics affect the manner
in which effectors bind to Arf and Rab proteins. Recently, several
newly determined crystal structures of Arfs and Rabs complexed
to their effectors have revealed common binding modes.
We begin our discussion by summarizing existing structural
knowledge and highlighting individual features of currently avail-
able Arf:effector and Rab:effector complex structures. Then, we
propose a new classification scheme for different modes of
Arf/Rab:effector binding. Additionally, we highlight structural
determinants that are the basis of Arf/Rab:effector specificity.
We conclude by expanding on functional implications that are
emerging from available structural information under our pro-
posed classification scheme.
Arfs/Rabs and Their Effectors
The Arf protein family consists of about 30 members that can be
divided into three groups: (1) the Arf GTPases, (2) the Arf-likeved
Figure 1. Structure-Based Sequence Alignment of Representative Arf, Rab, Ras, Rho, Ran, and RGK Proteins
The secondary structure of the minimal G domain of ARF1 is shown above the sequence alignment. The P loop is black, switch 1 is red, the interswitch is green,
and switch 2 is blue. The glycine insertion in Arf, Rab, and Ran is highlighted in pink. The three residues that comprise the aromatic triad in Arfs and Rabs are
highlighted in yellow. Residues that aremodified by lipid enzymes to enablemembrane attachment are highlighted in green. RabSF and RabFmotifs are framed in
orange.
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ReviewGTPases (Arls), and (3) secretion-associated and Ras-related
GTPases. Previous analyses of seven Arf:effector complexes
provided a structural understanding of effector recruitment by
the Arf family (Chavrier and Me´ne´trey, 2010). More recent
studies have increased the number of known crystal structures
to 11 Arf:effector complexes (Table S1 available online).
Notably, four of these effectors consist of a single globular
domain (BART, CTA1, PDEd, and UNC119a) and have been
crystallized in their entirety as complexes with their cognate
Arfs. A gallery of Arf:effector complex structures is shown in
Figure 2, and more detailed descriptions of their features are
given in the following sections.StructARF1:GGA Structure
Golgi-localized, gamma-ear-containing, ARF-binding (GGA)
proteins are monomeric clathrin-associated adaptor proteins
involved in the trafficking of cargo between the trans-Golgi
network and endosomes (Bonifacino, 2004). GGAs are multido-
main proteins containing a central GGA and TOM1 (GAT) domain
that has been identified as the key region interacting with Arf.
One interesting study identified GGA proteins as modulators of
retrovirus release and Arf proteins as cellular cofactors in retro-
viral trafficking (Joshi et al., 2008). The crystal structure of a com-
plex between ARF1 and the N-terminal part of the GAT domain
(N-GAT) shows that N-GAT folds as a helix-loop-helix structureure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1285
Figure 2. Gallery of 3D Structure of Arf:Effector Complexes
Arf proteins are in the same orientation and are colored in gray with the switch 1 in red, the interswitch in black, and the switch 2 in blue. All the effectors are shown
in yellow and orange to indicate the second molecule of dimeric effectors. See Table S1 for structural information on the Arf:effector complexes.
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Review(Shiba et al., 2003). The two helices of N-GAT are positioned
against the b sheet of the interswitch and interact with switches
1 and 2 of ARF1. The crystal structure supports previous muta-
tional data that highlight Asn194 of GGA1N-GAT as a critical res-
idue for the interaction with ARF1 (Puertollano et al., 2001).
ARF1:ARHGAP21 Structure
ARHGAP21 (also named ARHGAP10) is a largemultidomain pro-
tein that exhibits RhoGAP activity. ARHGAP21 also interacts
with several other proteins including b-arrestin-1, which inhibits
its GAP activity and regulates the temporal activation of RhoA
(Anthony et al., 2011). ARHGAP21 binding to a-tubulin is
involved in remodeling of cell-cell junctions (Barcellos et al.,
2013). ARHGAP21 is also recruited by ARF1 to the Golgi com-
plex where it regulates F-actin dynamics by controlling nucle-
ation through Cdc42 and Arp2/3 complexes (Dubois et al.,
2005). The Arf-binding domain (ArfBD) of ARHGAP21 consists
of a PH domain and a subsequent C-terminal a helix (aCter helix)
(Dubois et al., 2005), which bind to ARF1 and ARF6 (Me´ne´trey
et al., 2007). The crystal structure of ARF1:ARHGAP21ArfBD
reveals that the aCter helix of ArfBD aligns along the interswitch,
making hydrophobic interactions with switches 1 and 2 of ARF1,
while the PH domain interacts mainly with switch 1 (Me´ne´trey
et al., 2007). Both the PH domain and the aCter helix are essen-1286 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights resertial for the binding of ArfBD to ARF1 and for recruitment of
ARHGAP21 to Golgi membranes, as shown by in vitro and in vivo
studies (Me´ne´trey et al., 2007).
ARF1:COPI Structure
COPI or coatomers belong to cytosolic coat protein complexes
(COPs) that self-assemble into spherical cages to sculpt the
membrane, capture cargo, and form vesicles (Lee et al., 2004).
COPI is a 550 kDa protein complex of seven COPs: a-, b-, b0-,
g-, d-, ε-, and z-COP. COPI-coated vesicles are involved in retro-
grade traffic from the Golgi and their assembly is initiated by the
activation of Arfs on the membrane (Lee et al., 2004). Recently,
the structure of gz-COP subunits bound to ARF1 has been deter-
mined (Yu et al., 2012). The first 315 residues of g-COP adopt a
curved superhelix of 15 a helices (an a-solenoid fold) that binds
as an arc around the z-COP subunit, which adopts a globular a/b
fold. Switches 1 and 2 of ARF1 interact with helices a4 and a6 on
the outer surface of the g-COP arc, while making no contact with
z-COP. Apart from two hydrogen bonds in the center of the inter-
face, the interactions are mainly hydrophobic.
ARF6:CT Structure
The cholera toxin (CT) of Vibrio cholerae, the major bacterial
agent of severe diarrheal diseases, is composed of a host cell-
translocation B subunit and a globular A subunit that is cleavedved
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tively low activity in vitro, but its affinity and enzymatic activity
toward the stimulatory G protein A subunit (GSa) is increased
upon interaction with GTP-bound Arfs, but not Arls in host cells
(Kahn and Gilman, 1986). CT-A1 is a single-domain protein
with a mixed a/b fold comprising a b sandwich core of two
perpendicular b sheets surrounded by helices (O’Neal et al.,
2004). The crystal structure of ARF6 complexed to the full A1
domain of CT shows that the Arf-binding site of CT-A1 consists
of loop regions with little secondary structure that rearrange to
form an amphipathic helix upon ARF6 binding (O’Neal et al.,
2005). CT-A1 binds to the switch and interswitch regions of
ARF6 predominantly through hydrophobic interactions.
ARF6:JIP4 Structure
JNK interacting proteins (JIPs) are scaffolds for JNK cascade
kinases and thus are important for brain development, neuronal
traffic, and apoptosis (Koushika, 2008). JIPs are also adaptors
linking cargo to kinesin-1, a major molecular motor for axonal
transport (Koushika, 2008). JIPs have been shown to play signif-
icant and complex roles in axonal transport via interaction with
multiple proteins. JIP3 and JIP4 interact specifically with ARF6,
which regulates JIP’s interaction with kinesin-1 and dynein/
dynactin motors, leading to the control of endosome recycling
to the plasma membrane (Montagnac et al., 2009). The structure
of the middle part of JIP4 adopts a leucine zipper (LZII) com-
plexed to two ARF6 molecules in a heterotetrameric assembly
(Isabet et al., 2009). This structure reveals that the long and rigid
coiled coil of JIP4LZII interacts with the interswitch and switch 2
regions of ARF6. The structure reveals for the first time how a
specific effector can discriminate between two Arfs, i.e., ARF6
and ARF1.
ARF6:MKLP1 Structure
Mitotic kinesin-like protein 1 (MKLP1), also known as KIF23,
together with MgcRacGAP/Cyk4, constitutes the centralspindlin
complex at the Flemming body. MKLP1 recruits ARF6 to
the Flemming body during cytokinesis (Makyio et al., 2012).
MKLP1 is a kinesin motor that interacts directly with ARF6
through its terminal tail domain (Makyio et al., 2012). The crystal
structure of the ARF6:MKLP1tail complex reveals that MKLP1tail
folds as a central b sheet surrounded by several a helices and
assembles as a dimer through the central b sheet (Makyio
et al., 2012). The MKLP1tail homodimer is flanked by two ARF6
molecules, forming a 2:2 heterotetramer that results in an
extended b sheet of 22 b strands spanning the entire complex.
ARF6 and MKLP1tail make antiparallel interprotein b sheet inter-
actions through their respective b2 and b5 strands, as well as
hydrophobic contacts at the interswitch and switch 2 regions.
ARL1:Golgin-245 Structure
Golgins are a family of large Golgi-localized proteins with
extended coiled-coil regions that play a role in tethering
cisternae and transport vesicles to Golgi membranes, thus
maintaining the overall architecture of the Golgi complex (Short
et al., 2005; Munro, 2011). Golgin-245 associates with Golgi
membranes by interacting specifically with ARL1 through a
C-terminal GRIP domain (Panic et al., 2003; Gillingham et al.,
2004). The crystal structure of ARL1:golgin-245GRIP reveals
that GRIP consists of an array of three antiparallel helices and
forms a tight homodimer that binds in a dyad-symmetric fashion
to two ARL1 molecules (Panic et al., 2003; Wu et al., 2004). TheStructinteraction is mediated by two adjacent helices of one GRIP
domain, which align along the b sheet of the interswitch and
recognize switches 1 and 2, respectively, of ARL1 mainly
through hydrophobic interactions.
ARL2:BART Structure
Binder of ARL2 (BART) was shown to be involved in mitochon-
dria transport and apoptosis (Sharer et al., 2002). BART is also
essential for nuclear retention of signal transducers and acti-
vators of transcription 3 (STAT3), and ARL2 binding to BART
enhances the interaction of BART with STAT3 (Muromoto
et al., 2008). Finally, BART is found to inhibit pancreatic cancer
cell invasion by inhibiting ARL2-mediated RhoA inactivation
(Taniuchi et al., 2011). The crystal structure of full-length
ARL2 complexed to BART shows that BART consists of a six
a-helix bundle and interacts with ARL2 through two interfaces
(Zhang et al., 2009). The first interface involves both hydropho-
bic and hydrophilic interactions between the switch regions
(primarily switch 1) of ARL2 with the helix a3 and a subsequent
loop of BART. The second interface involves extensive hydro-
phobic interactions between the N-terminal amphipathic a helix
of ARL2 and the hydrophobic cleft formed by helices a3, a4,
and a5 of BART. The latter interaction is the first to demonstrate
that the N-terminal helix can be a key determinant of Arf:effec-
tor recognition.
ARL2/3:PDEd and UNC119a Structures
Delta subunit of phosphodiesterase (PDEd) and UNC119 pro-
teins (a and b isoforms) are homologous proteins that share a
similar structural fold consisting of an immunoglobulin-like
b sandwich (Hanzal-Bayer et al., 2002; Ismail et al., 2012). The
b fold contains a hydrophobic pocket that accommodates lipid
moieties of posttranslationally modified membrane-associated
proteins (Hanzal-Bayer et al., 2002; Ismail et al., 2012; Wright
et al., 2011; Zhang et al., 2011). These proteins act as solubilizing
factors for lipidated cargoes and play a critical role in ciliary traf-
ficking (Ismail et al., 2011, 2012). The structures of ARL2:PDEd,
ARL2:UNC119a, and ARL3:UNC119a were determined using
full-length proteins (Hanzal-Bayer et al., 2002). Overall, the inter-
faces are similar and formed primarily by a parallel interprotein
b sheet interaction involving b2 of the interswitch region of
ARL2/3 and b7 of PDEd/UNC119, resulting in a 10-stranded
b sheet. Additionally, PDEd/UNC119 interacts with the switch 2
and interswitch regions of ARL2/3 in a hydrophobic manner.
Interestingly, the switch regions of Arf proteins recruit effec-
tors that exhibit diverse folds. The Arf-binding domains of effec-
tors range from all-a-helical to all b sheet, or a combination of
the two, as illustrated by a pleckstrin homology (PH) domain
followed by a single helix found in a number of effectors.
The Rab proteins constitute the largest family of small
GTPases with more than 60 members in mammalian cells. A
total of 14 independent Rab:effector complexes has now been
deposited in the Protein Data Bank (Table S2). Rab effectors
that are structural homologs can be counted as a single com-
plex; thus, there are effectively 9 distinct Rab:effector structures
that are known. All of the effectors have been truncated from
their full-length parents and generally contain the minimal Rab-
binding domain (RBD) that imparts the full affinity and specificity
for their cognate Rabs. A gallery of Rab:effector complex struc-
tures is shown in Figure 3, andmore detailed descriptions of their
features are provided below.ure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1287
Figure 3. Gallery of 3D Structures of Rab:Effector Complexes
Rab proteins are in the same orientation and are colored in gray with the switch 1 in red and the switch 2 in blue. All the effectors are shown in light and dark green
to indicate the second molecule of dimeric effectors. See Table S2 for structural information on the Rab:effector complexes.
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Rab3 and Rab27 mediate exocytosis in numerous cells
including neurons, lymphocytes, and epithelial cells (Yi et al.,
2002). Rab27-mediated transport pathways are compromised
in patients with Griscelli disease, an inherited autosomal disorder
associated with albinism, immune deficiency, and neurological
disorders (Me´nasche´ et al., 2000; reviewed in Khan, 2013). The
structure of Rab3:Exophilin-1 (also called Rabphilin-3) was the
first Rab:effector complex determined by X-ray crystallography
(Ostermeier and Brunger, 1999). Recently, the structures of
Rab27:Slp2-a and Rab27:Slac2-a (also known as melanophilin)
have also been determined (Chavas et al., 2008; Kukimoto-Niino
et al., 2008). All of these effectors contain a conserved N-termi-
nal Rab27-binding domain (RBD27), although some of them are
promiscuous. For example, Exophilin-1 can be recruited by
Rab3 and Rab27 (Fukuda, 2006; Itzen and Goody, 2008; Kuki-
moto-Niino et al., 2008). The RBD27 consists of an a-helical
hairpin motif that interacts with the switch and interswitch
regions of Rabs. In many of these motifs such as Exophilin-1
and Slac2-a, a Zn2+-binding globular domain is inserted between
the two a helices.
Rab4/22:Rabenosyn-5 Structures
Rabenosyn-5 is implicated in the regulation of endocytic
trafficking pathways (Nielsen et al., 2000). Its interaction with
Rab4/Rab22 mediates the transport of clathrin-coated vesicles1288 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserfrom the plasma membrane into early endosomes (Navaroli
et al., 2012). Rabenosyn-5 contains a Zn2+-associated FYVE-
finger domain, situated near its N terminus (Nielsen et al.,
2000), which mediates lipid binding. Rab4 and Rab22 bind to
discrete motifs of Rabenosyn-5, although the two motifs are
structurally identical (Eathiraj et al., 2005). Crystal structures of
the complexes Rab4:Rabenosyn-5 and Rab22:Rabenosyn-5
have been determined (Eathiraj et al., 2005). The structure of
Rabenosyn-5 consists of two helices connected by a short
loop (an a-helical hairpin), and binding to Rab4 is mediated by
switch 1/2 and the interswitch regions.
Rab5:EEA1 Structure
Early endosomal autoantigen 1 (EEA1) enhances endosomal
fusion throughout its interactions with Rab5 (Callaghan et al.,
1999a) and several other soluble factors, including Rabenosyn-
5, hVPS45, and Rabex-5, an exchange factor for Rab5 (Simon-
sen et al., 1998; Christoforidis et al., 1999; Nielsen et al., 2000;
Ohya et al., 2009). EEA1 is composed of an N-terminal zinc
finger, followed by coiled-coil regions and a C-terminal FYVE
finger domain (Callaghan et al., 1999b). The N-terminal Zn2+
finger has high affinity for Rab5, and the crystal structure of
Rab5 with this domain has recently been determined (Mishra
et al., 2010). The Zn2+ finger motif (C2H2) adopts a bba topology
with the a helix and b1 strand engaging the switch and inter-
switch regions of Rab5. The complex was the first example ofved
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into the structural basis for Rab5 specificity.
Rab5:Rabaptin5 Structure
Rabaptin-5 is a multidomain protein that regulates endocytic
trafficking (Stenmark et al., 1995; Gournier et al., 1998). In addi-
tion to Rab5, Rabaptin-5 contains a separate binding site for
Rab4 (Vitale et al., 1998); thus, it may provide a molecular link
between two Rab trafficking pathways. The dynamics of Rab5
activity are also regulated by Rabex-5, a GEF for Rab5 that
also interacts directly with Rabaptin-5 to promote endosome
fusion and endocytosis (Zhu et al., 2007). The crystal structure
of Rab5-GTP complexed to the RBD of Rabaptin-5 reveals a het-
erotetrameric assembly (Zhu et al., 2004). The RBD of Rabaptin-
5 forms a central symmetric coiled coil, which binds to two Rab5
molecules on either side. The two Rabs do not contact each
other, and this is a recurring theme in Rab:effector oligomers
mediated by symmetric coiled coils. Like most Rab:effector
complexes, recruitment is mediated by the switch 1/2 and
interswitch regions.
Rab6:GCC185 Structure
GRIP and coiled-coil domain-containing protein (GCC185) is a
large protein that contains long stretches of coiled coils and
mediates trafficking from late endosomes to the trans-Golgi
network (Kooy et al., 1992; Fritzler et al., 1993; Barr and Short,
2003; Reddy et al., 2006; Derby et al., 2007). In addition to
Rab6, GCC185 apparently contains a nonoverlapping site for
ARL1 binding, termed the GRIP domain. Structural studies and
in vitro assays suggest that Rab6 binding to GCC185 enables
more efficient loading of ARL1 onto the GRIP domain (Burguete
et al., 2008), although an alternative study finds no link between
ARL1 and GCC185 localization (Houghton et al., 2009). More
recently, GCC185 has been identified as an effector of ARL4,
and the complex apparently maintains the integrity of Golgi com-
partments (Lin et al., 2011). The structure of Rab6 in complex
with a short a-helical motif from GCC185 has been determined
(Burguete et al., 2008). Like Rab5:Rabaptin-5, the complex of
Rab6:GCC185 is a heterotetramer in which the effector forms
a central symmetric coiled coil. Again, effector recruitment is
mediated by the switch 1/2 and the interswitch regions.
Rab6:DENND5 Structure
DENND5 (alternatively, Rab6-interacting protein 1, or Rab6IP1)
is a large multidomain protein that contains a series of differen-
tially expressed in normal versus neoplastic cells (DENN)
domains at its N terminus. DENND5 is recruited by Rab6 and
regulates traffic into and out of the Golgi apparatus (Miserey-
Lenkei et al., 2007). The C-terminal half of DENND5 consists of
two RUN domains separated by a PLAT domain. The structure
of Rab6 in complex with RUN1-PLAT domains of DENND5 has
been determined and reveals that the first all-a-helical RUN
domain mediates binding to the switch and interswitch regions
of Rab6 (Recacha et al., 2009). The first and last a helices of
the RUN1 domain (a1 and a8) stack in a parallel fashion and
interact with Rab6. No direct interaction is observed between
the PLAT domain of DENND5 and Rab6.
Rab7:RILP Structure
Rab-interacting lysosomal protein (RILP) recruitment by Rab7
mediates fusion of phagocytic vesicles with late endosomes
and/or lysosomes (Harrison et al., 2003). More recently, RILP
and RILP-related proteins have been identified as effectorsStructfor Rab36 in mediating retrograde transport of melanosomes
(Matsui et al., 2012). Rab7 interacts directly with a domain
(RBD) situated in the middle of RILP, and the crystal structure
of Rab7:RILP-RBD has been determined (Wu et al., 2005). The
RBD adopts a helical hairpin motif that dimerizes and binds to
two Rab7 molecules on equivalent and opposite sides of the
effector. The RBD dimer is enabled by both a helices in the
helical hairpin, such that the two helical hairpins interdigitate
with each other. In addition to the switch and interswitch regions,
the C-terminal helix of RBD engages CDR3 (C terminus) and the
N-terminal helix engages CDR1 (N terminus) of Rab7, thus
forming an extensive interface.
Rab8:OCRL1 Structure
Oculocerebrorenal syndrome of Lowe protein 1 (OCRL1) regu-
lates vesicle trafficking from early endosomes to Golgi (Choud-
hury et al., 2005), endocytic recycling (Noakes et al., 2011), as
well as cell migration (Coon et al., 2009). The Rab-binding region
of OCRL1 was localized to a segment of the protein ASPM-SPD-
2-Hydin, termed the ASH domain (Hyvola et al., 2006). The struc-
ture of Rab8 in complex with the RBD from OCRL1 has been
determined (Hou et al., 2011). The RBD folds as an N-terminal
a helix followed by a b sandwich that resembles immunoglobulin
domains. Binding is mediated by b9 of the ASH domain, which
interacts with the switch and interswitch regions of Rab8. Addi-
tional interactions between switch 1/interswitch and the a helix/
linker precede the ASH domain of OCRL1. The Rab:effector
complex is unusual in the extent of interactions between
OCRL1 and the interswitch.
Rab11:FIP Structures
Rab11-family interacting proteins (FIPs) regulate various aspects
of endosomal trafficking including receptor recycling (Ren et al.,
1998) and delivery of cargo to the growing cleavage furrow in cell
division (Wilson et al., 2005). FIPs are multidomain effectors that
comprise a highly conserved RBD11 at their extreme C termini.
Rab25 also binds to FIPs and its activity has been linked to the
aggressiveness of carcinomas in recent years (Cheng et al.,
2004; Caswell et al., 2007; Goldenring and Nam, 2011). Three
related structures of Rab11 in complex with members of FIPs
have been crystallized (Eathiraj et al., 2006; Jagoe et al., 2006;
Shiba et al., 2006). The butterfly-shaped complex is assembled
as a heterotetramer with RBD11 forming a central coiled coil
with equivalent Rab11-binding sites on each side. Unusually,
the switch 2 conformation of Rab11 is nonhelical and undergoes
a conformational rearrangement upon binding to FIPs. The
nonhelical and flexible nature of switch 2 has been presumed
to be a determinant of Rab11:FIP specificity.
Rab proteins also recruit, mainly through their switch regions,
structurally diverse effector proteins. However, the vast majority
of known RBDs adopt an a-helical conformation. Nevertheless,
there are now two examples of RBDs that contain a non-
helical segment that binds to Rabs. Altogether, the preceding
Arf/Rab:effector structures highlight recurrent modes of binding
shared by these small GTPase families.
Arf/Rab:Effector Binding Modes
As indicated in the summary of structural data available from Arf/
Rab:effector complexes we provided earlier, these complexes
can be organized into distinct groups based on their mode of
binding, despite unrelated sequences and folds of the effectors.ure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1289
Figure 4. Arf/Rab Modes of Binding
(Left) All-a-helical mode of binding.
(Middle) Mixed a-helical mode of binding.
(Right) b-b zipping mode of binding. Arf/Rab proteins are shown in light gray with the switch regions in dark gray. Effectors are indicated in a rainbow spectrum
from the N terminus in blue to the C terminus in red.
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structural insights are all-a-helical, mixed a-helical, b-b zipping,
and bivalent modes of binding. We offer details of individual
modes below and argue that such a conceptual organization
can be useful in understanding the structural basis for specificity
and biological function.
All-a-Helical Mode of Binding
Many Arf/Rab-binding domains adopt an all-a-helical conforma-
tion ranging from coiled-coil structures (JIP4, FIP2/3, GCC185,
and Rabaptin-5) to a-helical bundles (GGA, g-COP, golgin245,
DENND5, and Rabenosyn5) or aspects of both (RILP). These
binding domains interact mainly using two helices packed along-
side the switch-interswitch junction of their Arf/Rab partners.
Interestingly, the two helices arise either fromdifferentmolecules
of a dimer, like JIP4 (Figure 4A), RILP (Figure 4B), Rabaptin5,
FIP2/3 (Figure 4C), and GCC185, or from the same molecule
being either contiguous, like golgin245 (Figure 4D), GGA
(Figure 4E), and Rabenosyn-5, or noncontiguous like g-COP
and DENND5 (Figure 4F). Differences are also observed in the1290 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights resertopology of the two helices relative to each other and to the
Arf/Rab interface. Overall, the structural data suggest that two
helices are the minimal motif necessary to bind Arf/Rab proteins
at the switch junction.
Mixed a-Helical Mode of Binding
Some Arf/Rab binding domains exhibit a single a helix that is
complementary to the switch-interswitch junction of the
GTPase. Interestingly, in this case a second interaction site is
observed outside the switch-interswitch junction that is critical
for the full binding affinity of the effector for its Arf/Rab partners.
This mode of binding is referred to as a mixed a-helical mode of
binding (Figure 4, middle panel). The ArfBD of ARHGAP21 com-
prises a single C-terminal helix that interacts with the switch-
interswitch junction of ARF1, but a second interaction is
made between the PH domain of ArfBD and switch 1 of ARF1
(Figure 4G; Me´ne´trey et al., 2007). Mutagenesis studies have
shown that neither the single helix nor the PH domain alone of
ArfBD is sufficient for binding ARF1—both are required (Me´ne´-
trey et al., 2007). Also, two interfaces have been reportedved
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comprises a single helix (a3) of BART that packs against the
switch-interswitch junction of ARL2. The second interface
includes three helices (a3, a4, and a5) of BART that interact
with the unique N-terminal helix of ARL2 (Zhang et al., 2009).
Structural and biochemical data demonstrate that here, also,
both interfaces are essential for the binding of ARL2 to BART
(Zhang et al., 2009). Interaction of the Rab27 family of effectors
(Slac2-a, Slp2-a, and Exophilin-1/Rabphilin-3) with Rab27 and
Rab3 involves two discrete parts of the Rab (Figure 4I). In addi-
tion to the packing of a single helix to the switch-interswitch
junction, the RBD consists of a globular zinc-stabilized subdo-
main that binds to a hydrophobic patch involving the comple-
mentarity-determining regions of Rab27/Rab3 (Ostermeier and
Brunger, 1999; CDR1, N-terminal a helix; CDR2, the a3–b5
loop; and CDR3, the C-terminal a helix; Figure 1). Furthermore,
the structures of Rab27:Slac2-a and Rab27:Slp2-a reveal that
the second a helix in the hairpin interacts with the C-terminal
end of the switch 2 a helix (Figure 4I). Presumably, both sets of
interactions are necessary for the full affinity of the complexes,
although detailed mutagenesis experiments have not been per-
formed. Altogether, these various examples suggest that binding
of a single a helix to switch-interswitch junctions alone is insuffi-
cient to provide the specificity and/or affinity necessary for
effector recruitment, and thus a second interface is required.
b-b Zipping Mode of Binding
Another common mode of binding observed for Arf/Rab effec-
tors is the formation of b-b zipping interactions made with the
b2 strand of the interswitch. Three examples highlight this
mode of binding in the Arf/Rab families (Figure 4, right panel)
(Hanzal-Bayer et al., 2002; Hou et al., 2011; Makyio et al.,
2012). In ARL2:PDEd and ARF6:MKLP1 structures (Figures 4J
and 4K), interactions take place via an interprotein b sheet inter-
action with the b2 strand of the interswitch either in a parallel
(PDEd) or antiparallel (MKLP1) orientation (Hanzal-Bayer et al.,
2002; Makyio et al., 2012). ARL2:PDEd and ARF6:MKLP1 com-
plexes exhibit seven and five hydrogen bonds, respectively, in
this b-b zipping interaction from each molecule of the complex.
The third example is the recent crystal structure of Rab8 in com-
plex with OCRL1 (Figure 4L; Hou et al., 2011). The b-b zipping
interaction between Rab8 and OCRL1 is antiparallel, like that
of ARF6:MKLP1, but it is shorter and involves three hydrogen
bonds. Interestingly, both PDEd and OCRL1 feature an N-termi-
nal helix followed by an immunoglobulin-like b sandwich domain
(Figures 4J and 4L). Although both PDEd and OCRL1 use their
respective b7 strand to make b-b zipping interactions with the
b2 strand of their partners, they do so differently. Indeed, the
b-b zipping interaction of ARL2:PDEd is parallel, whereas that
of OCRL1 is antiparallel (Figures 4J and 4L). This difference situ-
ates the N-terminal helix of OCRL1 ahead of the b sandwich and
in contact with the tip of the interswitch of Rab8, while that of
PDEd makes no contact with ARL2. Another interesting point in
these three Arf/Rab effectors is that the strand involved in the
b-b zipping interaction is part of a b sheet, thus resulting in a
contiguous b sheet that extends over both molecules.
Bivalent Mode of Binding
Several Arf/Rab:effector complexes assemble as heterote-
tramers with the Arf/Rab-binding domains forming a central
symmetric homodimer (Figure 5). The homodimeric effectorsStructbind to two Arf/Rab molecules on equivalent and nonoverlap-
ping sides. Given that all known active Arf/Rab proteins are
monomers, symmetric dimers enable the oligomerization of
Arf/Rab:effector complexes that may be relevant to biological
activity. This assembly has previously been called a bivalent
mode of binding (Kawasaki et al., 2005; Panic et al., 2003).
Among the 10 Arf:effector complexes, 3 have been charac-
terized as heterotetramers—ARL1:golgin245, ARF6:JIP4, and
ARF6:MKLP1 (Figures 5A–5C). A survey of this mode of binding
in the Arf family reveals several variants that are adopted by
the complexes. The GRIP domain of golgin245 dimerizes as a
three-helix bundle, the LZII of JIP4 is a coiled-coil structure,
and the tail of MKLP1 ismainly an all b sheet structure that dimer-
izes through a b-b zipping interaction (Figures 5A–5C). Whereas
eachmonomer of golgin245-GRIP andMKLP1-tail interacts with
one molecule of ARL1 and ARF6, respectively, each monomer
from the JIP4-LZII interacts with the two ARF6 molecules. Of
note, g-COP and b-COP subunits of coatomer are evolutionarily
related and will likely have a similar overall structure. Biochem-
ical data and mutagenesis strongly support a model in which
ARF1 binds not only to g-COP, but also to b-COP in a similar
fashion, although the atomic details differ somewhat (Yu et al.,
2012). Taken together with the finding that ab0ε-COP does not
bind to ARF1, these results imply that heptameric coatomer
has two binding sites for ARF1 and thus can be recruited
in a bivalent manner to membranes (Yu et al., 2012). In the
case of Rab:effector complexes, four belong to this category—
Rab5:Rabaptin-5, Rab11:FIPs, Rab6:GCC185, and Rab7:RILP
(Figures 5D–5G). In contrast to the structural variety observed
for Arf:effector structures, all of these Rab-binding domains are
coiled coils. However, the orientation of effector a helices is var-
iable, with the long axis of Rabaptin5 rotated by 60 relative to
FIPs and GCC185 (Figures 5D–5F). Moreover, despite a similar
orientation of the long axis, the parallel a helices of FIPs and
GCC185 are topologically inverted relative to each other (Figures
5E and 5F).
As previously discussed, such a bivalent mode of binding with
two Arf/Rab molecules interacting with a dimeric effector at the
membrane would increase the effector residence time at the
membrane (Panic et al., 2003; Kawasaki et al., 2005). Indeed,
one of the Arf/Rab molecules could remain associated with the
membrane without inactivation, while the second could in theory
dissociate from the effector, be inactivated, and be replaced by a
new active Arf/Rab. Increasing residence time of the effectors on
the membrane may be essential for Arf/Rab-mediated trafficking
processes. However, such a bivalent mode of recruitment also
imposes a restricted orientation to the dimeric effectors relative
to the membrane. Notably, because Arfs are more closely
attached to the membrane bilayer than Rabs are, the orientation
of their dimeric effectors is more restricted. To prevent steric
hindrances between the membrane and polypeptide, the ArfBD
of these effectors must be situated either at the N/C termini or in
the middle of the polypeptide with a ‘‘U-turn’’ kink, thus allowing
the effectors to project into the cytosol to fulfill their functions.
Thus far, the structures of all known homodimeric effectors
conform to these structural constraints. Golgin245, Rabaptin5,
and FIP2/FIP3 (Figures 5A, 5D, and 5E) have their Arf/Rab-bind-
ing site at their extreme C termini, whereas the centrally located
Rab7-binding site of RILP (Figure 5G) adopts a helix-loop-helixure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1291
Figure 5. The Bivalent Mode of Binding of Arf/Rab:Effector Complexes
All the Arf/Rab:effector complexes are modelized relative to the membrane bilayers. Arf/Rab proteins are shown in light gray with the switch regions in dark gray.
Effectors are indicated in a rainbow spectrum from the N terminus in blue to the C terminus in red. Lipid modification of Arf/Rab proteins as well as N/C terminus
domains (not crystallized) of the effectors are schematized.
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opposite to the membrane. MKLP1 and GCC185 (Figures 5C
and 5F) have their respective Arf/Rab-binding domains close
to the extreme C terminus, although the N-terminal 100 residues
are missing from these structures. In the case of MKLP1, this
extreme C-terminal segment should not induce membrane
steric hindrance because both C termini extend away from the
membrane. In the case of GCC185, the hypervariable C-terminal
extension of Rab6 has been proposed to be long enough to
accommodate the remaining C-terminal part of GCC185 with-
out membrane steric hindrance (Burguete et al., 2008). One
exception is the extended coiled coil of JIP4, which contains
the ARF6-binding domain in the middle part of the protein. In
this case, we have suggested that the formation of a heterote-
tramer of ARF6:JIP4 will probably induce severe steric conflicts
between JIP4 and the membrane. Thus, JIP4 will likely be
recruited to the membrane by a single ARF6 molecule (Isabet
et al., 2009).1292 Structure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserIn summary, Arfs and Rabs complexed to their effectors share
four distinct modes of binding. Of note, the bivalent mode is not
restricted to a-helical coiled coils—the b-b zipping mode in
the ARF6:MKLP1 complex enables assembly of a heterotetra-
meric complex. Bivalent modes likely enable longer lifetimes of
complexes, which may be relevant for tethering and vesicle
biogenesis/fusion. Binary complexes with large surface areas
of interaction, such as Rab27:effector complexes, are suffi-
ciently strong to enable both specificity and motility via myosins.
Structural Basis for Effector Specificity
A global analysis of the crystal structures of Arf/Rab:effectors
and comparisons with other small GTPases in the Ras superfam-
ily highlight structural determinants of effector specificity that
distinguish the Arf/Rab families. The aromatic triad is a well-
established structural hallmark shared by Arf and Rab proteins.
Also, a contiguous hydrophobic interface at the junction of
switches 1 and 2 as well as sequence variability at the peripheryved
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Arf/Rab GTPases.
The Aromatic Triad
The hydrophobic triad was first identified and described in Rab
proteins and was proposed to be a major structural determinant
for effector binding and specificity (Merithew et al., 2001). The
hydrophobic triad is composed of an invariant tryptophan
residue in the interswitch and a phenylalanine and tyrosine/
phenylalanine residue situated adjacent to switch 1 and switch
2, respectively (Figure 1). Arf proteins also share the sequence
and position of the hydrophobic triad with Rab proteins, except
for the switch-1-proximal phenylalanine, which is found two res-
idues upstream (Figure 1). Because the hydrophobic triad in Arf
and Rab proteins consists of aromatic residues, we refer here-
after to this motif as an ‘‘aromatic triad.’’ Like Rabs, the aromatic
triad in Arf proteins is proposed to be a structural determinant for
effector specificity (Chavrier and Me´ne´trey, 2010). Global ana-
lyses of Arf/Rab:effector complexes reveal that the manner by
which effectors discriminate their Arf versus Rab partners
appears to be divergent. In Arf proteins, sequence variability is
found among subgroups, thus enabling effectors to discriminate
among them. In contrast, Rab sequences are more highly
conserved, but conformational variability in side-chain rotamers
is observed that may partly confer specificity to effector recogni-
tion between the various Rab proteins (Merithew et al., 2001). Of
note, no such aromatic triad is found at the same location in Ras,
Rho, Ran, and RGK families (Figure 1).
In Arf proteins, the aromatic triad has been identified as an
important structural determinant for effector binding. In the
case of the ARL1:golgin-245 complex, the aromatic triad of
ARL1 makes interactions with the Met2194 of golgin-245; its
mutation to alanine abolishes ARL1-mediated targeting of gol-
gin-245 to Golgi membranes (Wu et al., 2004). Interestingly,
UNC119a has been crystallized pairwise with ARL2 and ARL3
proteins, which share 62% sequence identities in their switch
regions. The structure of these complexes reveals differences
at their interface. In ARL2:UNC119a, the Trp62 side chain adopts
a novel rotamer, distinct from all other Arf:effector complex
structures, including that of ARL3:UNC119a. More specifically,
Trp62 of ARL2 is involved in hydrogen bondswith themain-chain
carbonyl of Phe179 and Phe181 from UNC119a, while that of
ARL3 makes only one hydrogen bond (Ismail et al., 2012).
Although ARL2 and ARL3 bind UNC119a with similar affinities,
only ARL3 allosterically displaces cargo by accelerating its
release by three orders of magnitude (Ismail et al., 2012). The
structural difference observed at the aromatic triad of ARL2
may account for the difference in cargo displacement. Thus, in
addition to sequence variability in the aromatic triad as a mech-
anism of effector discrimination (Chavrier and Me´ne´trey, 2010),
conformational variability also plays a role in Arf:effector speci-
ficity, as observed in Rab proteins (see below).
In Rabs, the aromatic triad forms a hydrophobic interface with
all known effector complexes except for Rab8:OCRL1. Despite
sequence conservation, the side-chain conformations of these
residues are variable and have been linked with effector speci-
ficity (Merithew et al., 2001; Grosshans et al., 2006). The Rab6
interfaces with GCC185 and DENND5, two structurally unrelated
effectors, reveal comparable determinants of hydrophobicity
(aromatic triad) and polar/electrostatic parity, suggesting a con-Structservation of chemistry at the Rab6 interface (Burguete et al.,
2008; Recacha et al., 2009). However, the interface promiscuity
between Rab6 and these two effectors is associated with struc-
tural plasticity of the aromatic triad, particularly variant c1 dihe-
dral angles for Phe50 (switch 1) and Trp67 (interswitch). Such a
conformational variability in the aromatic triad of Rab6 probably
accounts for the ability of these two structurally unrelated effec-
tors to interact at the same location (Burguete et al., 2008; Reca-
cha et al., 2009). One exception is the structure of Rab8:OCRL1
in which the aromatic triad has only a peripheral involvement in
effector binding. Given that OCRL1 also binds to Rab1, Rab5,
and Rab6, which are evolutionarily divergent Rabs, it has been
suggested that abolition of an interface at the aromatic triad
may lead to effector promiscuity (Hou et al., 2011). An alternative
(and somewhat correlated) view is that the low affinities
observed in these complexes (Kd of 1–4 mM) implicate the aro-
matic triad as a significant component of the affinity in effector
binding.
Hydrophobic Surface at the Junction of Switches 1 and 2
In the active GTP-bound state of small GTPases, the C terminus
of switch 1 and the N terminus of switch 2 are brought into spatial
proximity with the g-phosphate of GTP via conserved hydrogen
bonds. These interactions enable a contiguous switch 1/2 bind-
ing surface for effector recruitment. In the case of Arf/Rab pro-
teins, the switch binding surfaces share structural properties
that are not observed in Rho and Ras family proteins. First, Arf/
Rab proteins have a glycine insertion at the C terminus of switch
1 relative to Ras/Rho proteins (Figure 1). Notably, Ran protein
also exhibits this glycine insertion at the same position. The
insertion facilitates the close apposition of the C-terminal part
of switch 1 to the N-terminal segment of switch 2. Second, Arf/
Rab proteins exhibit a hydrophobic patch that spans the switch
1/2 interface. This hydrophobic surface is adjacent to the
invariant glycine and extends toward the interswitch region
encompassing the aromatic triad. Thus, a contiguous hydropho-
bic interface, spanning elements from switch 1 to interswitch to
switch 2, appears to be critical for the formation of a complemen-
tary interface with Arf/Rab effectors (Figure 6). Altogether, the
glycine insertion and hydrophobic/aromatic residues from
switch regions lead to similar structural features adopted by
Arf and Rab proteins (Figures 6A and 6B) compared to Ras
and Rho proteins (Figures 6C and 6D), which likely accounts
for shared modes of effector binding.
In Arf proteins, the area that encompasses the hydrophobic
surface formed at the switch 1/2 junction and the aromatic triad
has been previously termed the common hydrophobic area
(CHA; Chavrier and Me´ne´trey, 2010). One difference with Rab
proteins is that the CHA of Arf proteins exhibits a hydrophobic
pocket (Figure 6A) where one residue from the effector can enter
more or less deeply. This hydrophobic pocket carries specificity
to discriminate among the different Arf subgroups (Chavrier and
Me´ne´trey, 2010). The recently solved ARF6:MKLP1 structure
(Makyio et al., 2012) reveals that MKLP1 also interacts with
ARF6 through its CHA using the hydrophobic pocket. It is inter-
esting to note that in contrast to the two other structures of effec-
tors complexed to ARF6, ARF6:JIP4 (Montagnac et al., 2009)
and ARF6:CTA1 (O’Neal et al., 2005), MKLP1 directs a volumi-
nous hydrophobic residue (phenylalanine) into the hydrophobic
pocket of ARF6 as deeply as the key tyrosine residue of theure 21, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1293
Figure 6. Structural Determinants of Effector Recruitment
Selected small GTPases are shown.
(Left) Ribbonmodels indicate the orientation of the effector interface relative to
the GTP. The glycine residue in switch 1 of ARF1 and Rab5 is indicated by a
magenta sphere to highlight its position relative to the hydrophobic interface.
(Right) The effector-binding interface is represented as water-accessible
surface. Basic and acid residues are indicated, respectively, in blue and
red, hydrophobic residues in yellow, and remaining residues are white. The
common hydrophobic area of ARF1 is indicated with a circle. Effectors are
represented as transparent gray worms and have been truncated to reduce
complexity and enable visualization of small GTPase surfaces.
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ReviewGRIP domain of golgin-245 complexed to ARL1 (Panic et al.,
2003; Wu et al., 2004).
Sequence Variability at the Edge of Switch Regions
One intriguing aspect in effector specificity is the ability of some
effectors to discriminate between two small GTPases that
belong to the same subgroup and thus are virtually identical in
sequence and structure at the switch junction. This observation
raises the question of how specificity takes place in such cases.
In the case of ARF1 and ARF6, which belong to the same Arf
subgroup and are structurally identical at the CHA region
(except for one conserved difference between switch 1 and
the interswitch), the determination of the ARF6:JIP4 complex
structure has revealed for the first time the structural determi-
nants of such specificity (Montagnac et al., 2009). In addition
to the CHA of ARF6, JIP4 makes specific interactions at the
edge of the switch regions, proximal to the CHA. At these posi-
tions, clear sequence differences between ARF1 and ARF6 are
sufficient to encode specificity, as shown by mutagenesis and
binding assays (Montagnac et al., 2009). Interestingly, because
these positions technically belong to the switch regions, they
could be sufficient to allow the effector to recognize the GTP-
bound form of the Arf protein without resorting to interactions
with the CHA. This would enable two distinct effectors, such
as GGA and FIP3 (Schonteich et al., 2007), to bind simulta-
neously to a single Arf protein—one at the CHA and the other
at the edge of the switch regions. In contrast to the Arf CHA,
the switch regions are narrower in Rab proteins, and therefore
GTP-specific recruitment of two effectors simultaneously would
be unlikely.
In the Rab family, sequence analyses have identified mamma-
lian-specific sequence motifs (RabF1–RabF5, Rab family) that
cluster within and adjacent to the switch regions (Figure 1;
Pereira-Leal and Seabra, 2000). Beyond the switch regions, it
was suggested that additional elements of the primary sequence
mediate effector specificity and biological function (Moore et al.,
1995; Ostermeier and Brunger, 1999). These regions were
termed the Rab subfamily motifs (RabSF1–RabSF3; Pereira-
Leal and Seabra, 2000), which partially overlap with the previ-
ously termed CDRs (Figures 1 and 4). Phylogenetic analyses of
Rabs suggest that sequence determinants in RabF and RabSF
motifs are conserved among functional groups (Pereira-Leal
et al., 2001), suggesting an evolution of distinct structural frame-
works for effector recruitment to mediate trafficking. The contri-
bution of RabSF motifs to effector binding may be direct—such
as RabSF1 (CDR1) in Rab27:effectors—or they may affect
the conformation of switch 1 (RabF1) and switch 2 (RabF2–
RabF4), thus indirectly influencing effector specificity (Figure 6).
Taken together, Rab sequences and Rab:effector complexes
have revealed subtle variations in active (GTP-bound) switch 1
and 2 conformations that encode effector specificity (Eathiraj
et al., 2005; Mishra et al., 2010). Thus, specificity is achieved
despite high sequence conservation in the switch regions and
a relatively narrow binding face in Rab proteins.
Conclusions
Although Arf and Rab families are relatively distant on the evolu-
tionary timeline, they jointly regulate vesicular trafficking, some-
times via a common effector. Despite their differences in
sequence and mechanism of membrane attachment, Arf andved
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that lead to common effector modes of binding. Two recurring
themes for Arf/Rab effector recruitment are all-a-helical and
bivalent modes of binding. More recent themes include mixed
a-helical modes, as well as b-b zipping that bridges two b sheets.
These binding modes are underpinned by a shared continuous
hydrophobic interface at the switch 1/2 junction that includes
the aromatic triad. Finally, for Arf and Rab families, the molecular
basis for effector specificity is a function of modest sequence
and structural variability situated at the aromatic triad and the
periphery of switch regions. In the future, it will be interesting
to examine how new Arf/Rab:effector structures follow these
general themes or whether new binding modes are exploited
to mediate trafficking in eukaryotic cells.
The long, extended conformations of many ArfBDs and
RabBDs appear suited for the microenvironment of membrane
surfaces. As shown by a proteomics analysis of the synaptic
vesicle (Takamori et al., 2006; Jahn and Fasshauer, 2012),
the surface of trafficking vesicles is dense and composed of
large transmembrane and membrane-associated glycoproteins.
Extended coiled coils would enable access to Rabs in a crowded
space, while also freeing the other globular domains to regulate
trafficking. It will be particularly exciting to observe develop-
ments in our understanding of Arf/Rab interactions with motor
proteins, such as myosins and kinesins, which regulate teth-
ering, motility, and fusion.
A limitation from structural studies of Arf/Rab:effector com-
plexes is the inability to wholly mimic the cellular environment
when extrapolating biological function. A full-length structural
model of a Rab effector remains to be determined, and in vivo,
cellular trafficking is affected by local concentrations of proteins
in lipidmicrodomains (Wang et al., 2002; Pfeffer, 2003; Heo et al.,
2006; Mizuno-Yamasaki et al., 2010). Also, posttranslational
modifications of effectors may affect the kinetics and affinity of
recruitment by Arf/Rab GTPases. Overall, these studies suggest
additional layers of regulation in a cellular context; integrative
structural, cellular, and biophysical approaches are required
to fully understand the molecular basis for trafficking by Arf
and Rab GTPases.
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